article thumbnail

Pharmaceutical Manufacturing And Packaging Congress 2022 Connects Pharma Leaders

The Pharma Data

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) covers the current state of the pharmaceutical manufacturing and packaging industry. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies.

article thumbnail

Case study: Extracting tidy data from Open Targets Genetics with Otargen

The Open Targets Blog

Amir has worked in the pharma/biotech sector for over ten years, using bioinformatics for data integration and multi-omics analysis for target identification and validation, and his team were an early adopter of Open Targets Genetics.  This is where our idea for an R package came from.    Have you used Otargen?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Best CDMO Practices for Startups: Navigating the Complex World of Contract Development and Manufacturing

Drug Patent Watch

The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. In 2017, small and medium-sized biotech companies accounted for 51% of FDA market approvals, while large pharma companies were the originators in only 28% of approvals[4].

article thumbnail

SOLABS & NexGen Analytics Partner to Offer Enhanced Reporting and Analytics Capabilities for the Life Sciences Industry

The Pharma Data

Full and complete packages resulting from this collaboration are expected to be made available in 2021 towards the end of the year. NexGen and SOLABS are already collaborating on client initiatives to deliver solutions to streamline decision processes and provide more visibility in the area of CAPAs, Change Control, Training Management, etc.

Science 52
article thumbnail

Q&A: The IND Journey Phase I – Navigating Success

Advarra

Q: What is the typical time period between the submission of the briefing package and the pre-IND meeting? A: The FDA’s guidance document indicates the briefing package is submitted four weeks before the meeting. The sponsor-initiated IND is conducted by a pharma company seeking commercial approval.

article thumbnail

Scaling Phage Therapy

Codon

But thankfully there are groups — from charities and start-ups to the non-profit arms of major pharma companies — looking specifically at more public-health-focused approaches to scaling phage therapy for these parts of the world. I cover this more extensively in The Good Virus.

Therapies 135
article thumbnail

Which Arthritis Painkiller Works the Fastest?

The Pharma Data

Unfortunately, I learned the hard way that the “Big Pharmacompanies don’t care about their patients. You should apply the MindBody Matrix Pain Relief cream 3-4 times per day for the first week after you receive your package. Why did the big pharmaceuticals maker under express or hide the potential for addictions with opiates.